Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

NASDAQ:SAVA

Overview | Financials
Company Name Cassava Sciences, Inc.
Symbol SAVA
Currency USD
Price 25.34
Market Cap 1,215,716,908
Dividend Yield 0%
52-week-range 8.79 - 42.2
Industry Biotechnology
Sector Healthcare
CEO Mr. Remi Barbier
Website https://www.cassavasciences.com

An error occurred while fetching data.

About Cassava Sciences, Inc.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known

Related Stocks

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.49 USD

Celularity Inc. logo

Celularity Inc.

CELU

3.09 USD

MannKind Corporation logo

MannKind Corporation

MNKD

7.39 USD

Veru Inc. logo

Veru Inc.

VERU

0.734 USD

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

59.81 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

28.44 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

3.19 USD

SomaLogic, Inc. logo

SomaLogic, Inc.

SLGC

2.1 USD

Innoviva, Inc. logo

Innoviva, Inc.

INVA

20 USD

Financials

Numbers are in millions USD

Numbers are in millions USD